GRFS vs ABBV: Which Stock is Better?
Side-by-side comparison of Grifols SA ADR and AbbVie Inc in 2026
GRFS
Grifols SA ADR
$7.63
ABBV
AbbVie Inc
$229.25
Key Metrics Comparison
| Metric | GRFS | ABBV | Winner |
|---|---|---|---|
| Market Cap | $5.08B | $401.24B | ABBV |
| P/E Ratio | 10.52 | 110.78 | GRFS |
| EPS (TTM) | $0.71 | $2.05 | ABBV |
| Revenue Growth | -0.0% | 0.1% | ABBV |
| Gross Margin | 38.4% | 72.0% | ABBV |
Analyze GRFS
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GRFS or ABBV a better investment?
Comparing GRFS and ABBV: Grifols SA ADR has a market cap of $5.08B while AbbVie Inc has $401.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GRFS and ABBV?
GRFS (Grifols SA ADR) and ABBV (AbbVie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GRFS or ABBV?
Based on P/E ratios, GRFS trades at a lower multiple (10.5x vs 110.8x).
Which is growing faster: GRFS or ABBV?
ABBV has higher revenue growth at 0.1% vs -0.0% for GRFS.
Which company is more profitable: GRFS or ABBV?
AbbVie Inc (ABBV) has higher gross margins at 72.0% compared to 38.4% for GRFS.
Which is the larger company: GRFS or ABBV?
AbbVie Inc (ABBV) is larger with a market cap of $401.24B compared to $5.08B for GRFS.
Should I buy GRFS or ABBV in 2026?
Both GRFS and ABBV have investment merit. GRFS trades at $7.63 while ABBV trades at $229.25. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GRFS and ABBV stock?
Key differences: Market Cap ($5.08B vs $401.24B), P/E Ratio (10.5x vs 110.8x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (38.4% vs 72.0%).
Should I buy GRFS or ABBV in 2026?
The choice between GRFS and ABBV depends on your investment goals. ABBV shows higher revenue growth (0.1%). ABBV has better margins (72.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GRFS and ABBV?
GRFS (Grifols SA ADR) has a market cap of $5.08B, while ABBV (AbbVie Inc) has a market cap of $401.24B. ABBV is the larger company by market value.